IIR's 13th annual business of biosimilars and generic drugs

FDA has been busy preparing for the day when the first biosimilar application is filed. In February, FDA published three draft guidance documents on biosimilars. In May, FDA held a public...

Pharmaceuticals/Drug Discovery, Industrial

Submit new post
Thank you for posting.
Share it:
No content found.
There seems to have been an error, please try again.